Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

NK-631 (peplomycin sulfate)

Known as: NK 631, NK-631, NK631 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
A new bleomycin derivative NK631 was administered in five cases of advanced recurrent oral carcinoma. The visible improvement of… 
1979
1979
Chronic toxicity and its recovery of pepleomycin sulfate was studied in both sexes of beagle dogs. At dose levels of 0.3, 0.15… 
1979
1979
1979
1979
NK 631, a new derivative of bleomycin, was clinically used in 14 cases of malignant tumors of skin. The results obtained were… 
1978
1978
The antimicrobial and antitumor activities, and the pulmonary toxicity of pepleomycin (NK631) were studied in comparison with… 
1978
1978
Studies on subactute toxicity and its recovery of pepleomycin sulfate (NK631) were carried out in both sexes of rats. NK 631 was… 
1978
1978
1. Organ distribution of pepleomycin (NK631) in mice and rats was studied. NK631 was found at higher levels than bleomycin (BLM… 
1978
1978
The comparative studies in the short term intermittent toxicity of pepleomycin (NK631) and bleomycin (BLM) were performed on 10… 
1978
1978
1. Whether NK 631 is antigenic to guinea pigs and rabbits was studied by the methods of active and passive anaphylactic shock…